# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-113881
Filing Date
2025-11-24
Accepted
2025-11-24 09:02:12
Documents
40
Period of Report
2025-11-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0266870-6k_enlivex.htm | 6-K | 46685
2 | FORM OF PRE-FUNDED WARRANTS | ea026687001ex4-1_enlivex.htm | EX-4.1 | 84187
3 | FORM OF LEAD INVESTOR WARRANTS | ea026687001ex4-2_enlivex.htm | EX-4.2 | 77483
4 | OPINION OF FISCHER (FBC & CO.), ISRAELI COUNSEL TO THE COMPANY | ea026687001ex5-1_enlivex.htm | EX-5.1 | 11530
5 | SECURITIES PURCHASE AGREEMENT | ea026687001ex10-1_enlivex.htm | EX-10.1 | 347470
6 | FORM OF REGISTRATION RIGHTS AGREEMENT | ea026687001ex10-2_enlivex.htm | EX-10.2 | 194232
7 | TREASURY MANAGEMENT AGREEMENT | ea026687001ex10-3_enlivex.htm | EX-10.3 | 128722
8 | FORM OF SHAREHOLDERS' AGREEMENT | ea026687001ex10-4_enlivex.htm | EX-10.4 | 64447
9 | ATM SALES AGREEMENT | ea026687001ex10-5_enlivex.htm | EX-10.5 | 244566
10 | SUPPLEMENTAL RISK FACTORS | ea026687001ex99-1_enlivex.htm | EX-99.1 | 94526
11 | PRESS RELEASE | ea026687001ex99-2_enlivex.htm | EX-99.2 | 19253
12 | INVESTOR PRESENTATION | ea026687001ex99-3_enlivex.htm | EX-99.3 | 36023
13 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 19192
14 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 2375
15 | GRAPHIC | ex99-3_001.jpg | GRAPHIC | 195530
16 | GRAPHIC | ex99-3_002.jpg | GRAPHIC | 812493
17 | GRAPHIC | ex99-3_003.jpg | GRAPHIC | 348653
18 | GRAPHIC | ex99-3_004.jpg | GRAPHIC | 312029
19 | GRAPHIC | ex99-3_005.jpg | GRAPHIC | 375806
20 | GRAPHIC | ex99-3_006.jpg | GRAPHIC | 378339
21 | GRAPHIC | ex99-3_007.jpg | GRAPHIC | 532689
22 | GRAPHIC | ex99-3_008.jpg | GRAPHIC | 268134
23 | GRAPHIC | ex99-3_009.jpg | GRAPHIC | 316907
24 | GRAPHIC | ex99-3_010.jpg | GRAPHIC | 290294
25 | GRAPHIC | ex99-3_011.jpg | GRAPHIC | 322469
26 | GRAPHIC | ex99-3_012.jpg | GRAPHIC | 433512
27 | GRAPHIC | ex99-3_013.jpg | GRAPHIC | 319662
28 | GRAPHIC | ex99-3_014.jpg | GRAPHIC | 314728
29 | GRAPHIC | ex99-3_015.jpg | GRAPHIC | 252906
30 | GRAPHIC | ex99-3_016.jpg | GRAPHIC | 344193
31 | GRAPHIC | ex99-3_017.jpg | GRAPHIC | 278782
32 | GRAPHIC | ex99-3_018.jpg | GRAPHIC | 337979
33 | GRAPHIC | ex99-3_019.jpg | GRAPHIC | 358457
34 | GRAPHIC | ex99-3_020.jpg | GRAPHIC | 300891
35 | GRAPHIC | ex99-3_021.jpg | GRAPHIC | 175144
36 | GRAPHIC | ex99-3_022.jpg | GRAPHIC | 366619
37 | GRAPHIC | ex99-3_023.jpg | GRAPHIC | 295241
38 | GRAPHIC | ex99-3_024.jpg | GRAPHIC | 456004
39 | GRAPHIC | ex99-3_025.jpg | GRAPHIC | 325824
40 | GRAPHIC | ex99-3_026.jpg | GRAPHIC | 332180
| Complete submission text file | 0001213900-25-113881.txt |  | 13840113

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 251509772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)